Chemocentryx, Inc.
(NASDAQ : CCXI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.37%86.271.3%$1304.25m
AMGNAmgen Inc.
0.97%203.881.2%$668.70m
GILDGilead Sciences, Inc.
0.77%69.180.9%$573.91m
LOXOLoxo Oncology Inc
0.11%233.5012.7%$483.46m
BIIBBiogen Inc.
-0.27%337.421.3%$447.04m
ILMNIllumina, Inc.
0.87%312.753.5%$347.89m
VRTXVertex Pharmaceuticals Incorporated
2.19%194.701.9%$335.60m
REGNRegeneron Pharmaceuticals, Inc.
0.35%418.842.6%$319.89m
ALXNAlexion Pharmaceuticals, Inc.
2.12%117.052.0%$239.84m
TSROTESARO, Inc.
0.03%74.9614.4%$182.44m
AAgilent Technologies, Inc.
2.10%72.311.5%$161.80m
INCYIncyte Corporation
-0.32%78.422.5%$154.32m
EXASExact Sciences Corporation
4.19%78.8025.3%$153.44m
SRPTSarepta Therapeutics, Inc.
1.22%122.8015.4%$139.57m
LGNDLigand Pharmaceuticals Incorporated
6.49%117.9023.1%$126.24m

Company Profile

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.